Lb Pharmaceuticals Common Stock Performance
| LBRX Stock | 15.33 0.46 2.91% |
The firm owns a Beta (Systematic Risk) of 0.23, which conveys not very significant fluctuations relative to the market. As returns on the market increase, LB Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding LB Pharmaceuticals is expected to be smaller as well. At this point, LB Pharmaceuticals Common has a negative expected return of -0.15%. Please make sure to verify LB Pharmaceuticals' total risk alpha, as well as the relationship between the accumulation distribution and period momentum indicator , to decide if LB Pharmaceuticals Common performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days LB Pharmaceuticals Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
Actual Historical Performance (%)
One Day Return (2.91) | Five Day Return 1.32 | Year To Date Return (11.39) | Ten Year Return (11.39) | All Time Return (11.39) |
1 | LB Pharmaceuticals Announces Pricing of its Upsized Initial Public Offering | 09/11/2025 |
2 | LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia, Including Positi... | 10/06/2025 |
3 | LB Pharmaceuticals Appoints James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs | 10/14/2025 |
4 | LB Pharmaceuticals Reports 3Q 2025 Financial Results and Recent Corporate Updates | 11/06/2025 |
5 | LB Pharmaceuticals amends lease to expand New York office space - Investing.com | 11/13/2025 |
| Begin Period Cash Flow | 15 M | |
| Total Cashflows From Investing Activities | 23.2 M | |
| Free Cash Flow | -53.8 M |
LB Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 1,730 in LB Pharmaceuticals Common on August 24, 2025 and sell it today you would lose (197.00) from holding LB Pharmaceuticals Common or give up 11.39% of portfolio value over 90 days. LB Pharmaceuticals Common is currently does not generate positive expected returns and assumes 4.0099% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than LBRX, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
LB Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LB Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LB Pharmaceuticals Common, and traders can use it to determine the average amount a LB Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0387
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LBRX |
Estimated Market Risk
| 4.01 actual daily | 35 65% of assets are more volatile |
Expected Return
| -0.15 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average LB Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LB Pharmaceuticals by adding LB Pharmaceuticals to a well-diversified portfolio.
LB Pharmaceuticals Fundamentals Growth
LBRX Stock prices reflect investors' perceptions of the future prospects and financial health of LB Pharmaceuticals, and LB Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LBRX Stock performance.
| EBITDA | (63.01 M) | ||||
| Net Income | (63.1 M) | ||||
| Total Debt | 3.7 M | ||||
| Cash Flow From Operations | (53.05 M) | ||||
| Total Asset | 33.53 M | ||||
| Retained Earnings | (104.32 M) | ||||
| Working Capital | 20.77 M | ||||
About LB Pharmaceuticals Performance
Evaluating LB Pharmaceuticals' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if LB Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LB Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.88) | (1.98) | |
| Return On Capital Employed | (2.55) | (2.42) | |
| Return On Assets | (1.88) | (1.98) | |
| Return On Equity | 0.67 | 0.36 |
Things to note about LB Pharmaceuticals Common performance evaluation
Checking the ongoing alerts about LB Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LB Pharmaceuticals Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LB Pharmaceuticals generated a negative expected return over the last 90 days | |
| LB Pharmaceuticals has high historical volatility and very poor performance | |
| LB Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (63.1 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LB Pharmaceuticals generates negative cash flow from operations | |
| LB Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: LB Pharmaceuticals amends lease to expand New York office space - Investing.com |
- Analyzing LB Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LB Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining LB Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LB Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of LB Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LB Pharmaceuticals' stock. These opinions can provide insight into LB Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for LBRX Stock Analysis
When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.